New warning issued about GLP-1 medications and possible vision loss
· Technology · CBS News, Global News
Federal health regulators have added a warning about possible vision loss linked to GLP-1 medications used for weight loss and diabetes. The alert specifically flags a rare eye condition where the clear tissue at the front of the eye becomes inflamed. Dr. Jon LaPook appeared on CBS Mornings to discuss the emerging safety signal. No definitive causal mechanism has been established, but the warning expands existing safety information for these widely prescribed drugs.
Why it matters
Patients currently using GLP-1 medications for diabetes or weight management face a new potential risk of developing inflammatory eye conditions, requiring heightened awareness and possible monitoring by healthcare providers.
Read the original report — CBS News
Join us on Telegram
Breaking news the moment it lands. At 10,000 members we ship the Android app.